Read by QxMD icon Read

AF and Heart Failure

shared collection
7 papers 0 to 25 followers
By Hua Fu
Dipak Kotecha, Jonathan P Piccini
Heart failure (HF) and atrial fibrillation (AF) are two conditions that are likely to dominate the next 50 years of cardiovascular (CV) care. Both are increasingly prevalent and associated with high morbidity, mortality, and healthcare cost. They are closely inter-related with similar risk factors and shared pathophysiology. Patients with concomitant HF and AF suffer from even worse symptoms and poorer prognosis, yet evidence-based evaluation and management of this group of patients is lacking. In this review, we evaluate the common mechanisms for the development of AF in HF patients and vice versa, focusing on the evidence for potential treatment strategies...
December 7, 2015: European Heart Journal
Sudarone Thihalolipavan, Daniel P Morin
Heart failure (HF) and atrial fibrillation (AF) commonly coexist, adversely affect mortality, and impose a significant burden on healthcare resources. The presence of AF and HF portends a poor prognosis as well as an increased thromboembolic risk. In patients whose AF is symptomatic, rhythm restoration with either antiarrhythmic drugs or procedural therapies (e.g., pulmonary vein isolation, either catheter-based or surgical) should be considered for symptom improvement, though a mortality benefit has yet to be demonstrated...
September 2015: Progress in Cardiovascular Diseases
Krzysztof Ozierański, Agnieszka Kapłon-Cieślicka, Michał Peller, Agata Tymińska, Paweł Balsam, Michalina Galas, Michał Marchel, Marisa Crespo-Leiro, Aldo Pietro Maggioni, Jarosław Drożdż, Grzegorz Opolski
BACKGROUND: Atrial fibrillation (AF) frequently coexists with heart failure (HF). AIM: To assess clinical characteristics and to identify predictors of one-year outcome of patients hospitalised for HF, depending on whether they were in sinus rhythm (SR) or had AF. METHODS: The study included Polish patients hospitalised for HF, participating in the Heart Failure Pilot Survey of the European Society of Cardiology, who were followed for 12 months after discharge...
2016: Kardiologia Polska
Matteo Anselmino, Mario Matta, Fabrizio D'Ascenzo, T Jared Bunch, Richard J Schilling, Ross J Hunter, Carlo Pappone, Thomas Neumann, Georg Noelker, Martin Fiala, Emanuele Bertaglia, Antonio Frontera, Edward Duncan, Chrishan Nalliah, Pierre Jais, Rukshen Weerasooriya, Jon M Kalman, Fiorenzo Gaita
BACKGROUND: Catheter ablation of atrial fibrillation (AFCA) is an established therapeutic option for rhythm control in symptomatic patients. Its efficacy and safety among patients with left ventricular systolic dysfunction is based on small populations, and data concerning long-term outcome are limited. We performed this meta-analysis to assess safety and long-term outcome of AFCA in patients with left ventricular systolic dysfunction, to evaluate predictors of recurrence and impact on left ventricular function...
December 2014: Circulation. Arrhythmia and Electrophysiology
Jan Povolný
Cardiomyopathy is a heterogeneous group of diseases of heart muscle accompanied with impaired cardiac function. Tachycardia-induced cardiomyopathy (TIC) is caused by prolonged tachycardia leading to dilatation and systolic dysfunction with clinical manifestation of heart failure. This state is reversible after normalization of heart rate. The diagnosis is usually made retrospectively after normalization of heart rate and recovery of left ventricular function (LVF). More than 100 years after the first documented case (described in 1913 in a young patient with atrial fibrillation and symptoms of heart failure [25]) is still limited knowledge of pathophysiological mechanisms...
January 2015: Vnitr̆ní Lékar̆ství
Tasso Julio Lobo, Carlos Thiene Pachon, Jose Carlos Pachon, Enrique Indalecio Pachon, Maria Zelia Pachon, Juan Carlos Pachon, Tomas Guillermo Santillana, Juan Carlos Zerpa, Remy Nelson Albornoz, Adib Domingos Jatene
BACKGROUND: Heart failure and atrial fibrillation (AF) often coexist in a deleterious cycle. OBJECTIVE: To evaluate the clinical and echocardiographic outcomes of patients with ventricular systolic dysfunction and AF treated with radiofrequency (RF) ablation. METHODS: Patients with ventricular systolic dysfunction [ejection fraction (EF) <50%] and AF refractory to drug therapy underwent stepwise RF ablation in the same session with pulmonary vein isolation, ablation of AF nests and of residual atrial tachycardia, named "background tachycardia"...
January 2015: Arquivos Brasileiros de Cardiologia
Steven K Carlson, Rahul N Doshi
Patients with newly diagnosed cardiomyopathy require careful assessment of cause and initiation of treatment before the decision is made to implant an internal cardiac defibrillator. In patients with medicine-refractory atrial fibrillation and cardiomyopathy, atrioventricular node ablation and implantation of a biventricular pacemaker is the therapy of choice when tachycardia-induced cardiomyopathy is suspected and curative therapy is not possible.
September 2015: Cardiac Electrophysiology Clinics
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"